Which has the lower trailing P/E, ABT or CVS?

CVS has the lower trailing P/E: ABT trades at 32.81 and CVS at 25.01. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or CVS?

Over the past five years, CVS grew revenue faster — ABT at a 2.98% CAGR versus CVS at 8.32%.

Does ABT or CVS pay a bigger dividend?

ABT yields 2.43% and CVS yields 2.81% based on trailing dividends and the latest price.

Is ABT or CVS more profitable?

ABT runs the higher net margin — ABT at 11.65% versus CVS at 1.18%.

How have ABT and CVS total returns compared?

Over the past 10 years, ABT delivered 11.61% and CVS delivered 3.48% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs CVS Health Corp. (CVS)

A side-by-side comparison of Abbott Laboratories and CVS Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$176.57B

$102.04HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT

CVS

CVS Health Corp.

$120.63B

$94.54HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT

Total return — ABT vs CVS

growth of $100 · dividends reinvested · last 10y

ABT +195.2% (+11.4%/yr)CVS +38.3% (+3.3%/yr)ABT compounded faster over this window

ABT CVS

ABT vs CVS: by the numbers

•ABT is the larger company ($176.57B vs $120.63B market cap).
•CVS trades at the lower trailing earnings multiple (25.01 vs 32.81 P/E), one valuation lens rather than an overall verdict.
•ABT converts more revenue to profit (11.65% vs 1.18% net margin).
•CVS grew revenue faster over the past five years (8.32% vs 2.98% CAGR).
•CVS pays the higher dividend yield (2.81% vs 2.43%).

Metrics side by side

Valuation

Metric	ABT	CVS
P/E ratio	32.81	25.01
Forward P/E	18.50	11.81
P/S ratio	3.79	0.29
P/B ratio	3.45	1.51
EV / EBITDA	18.74	14.49
FCF yield	4.49%	9.75%

Profitability

Metric	ABT	CVS
Gross margin	56.80%	14.15%
Operating margin	17.03%	2.00%
Net margin	11.65%	1.18%
ROE	10.61%	6.16%
ROIC	6.07%	4.14%

Dividends

Metric	ABT	CVS
Dividend yield	2.43%	2.81%
Payout ratio	79.74%	70.37%

Growth (annualized)

Metric	ABT	CVS
Revenue CAGR (5Y)	2.98%	8.32%
EPS CAGR (5Y)	8.22%	-23.89%
FCF CAGR (5Y)	0.18%	-10.28%
Total return CAGR (5Y)	-2.69%	5.91%

Frequently asked

Which has the lower trailing P/E, ABT or CVS?: CVS has the lower trailing P/E: ABT trades at 32.81 and CVS at 25.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or CVS?: Over the past five years, CVS grew revenue faster — ABT at a 2.98% CAGR versus CVS at 8.32%.
Does ABT or CVS pay a bigger dividend?: ABT yields 2.43% and CVS yields 2.81% based on trailing dividends and the latest price.
Is ABT or CVS more profitable?: ABT runs the higher net margin — ABT at 11.65% versus CVS at 1.18%.
How have ABT and CVS total returns compared?: Over the past 10 years, ABT delivered 11.61% and CVS delivered 3.48% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full CVS analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio CVS Health P/E ratio Abbott Laboratories dividend yield CVS Health dividend yield Abbott Laboratories ROE CVS Health ROE Abbott Laboratories operating margin CVS Health operating margin Abbott Laboratories revenue growth CVS Health revenue growth Abbott Laboratories free cash flow CVS Health free cash flow

Abbott Laboratories & CVS Health appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.